The tool we always wanted.

Faraday Bio was founded in 2025 to close the gap between analytical and preparative electrophoresis — a gap the founding team lived with across two decades building the industry's incumbent instruments. Intabio ZT, Simple Western, Maurice. Exoria is the platform we built to close it.

Founders who've shipped this category.

Erik Gentalen

CEO · Co-founder · Manchester, NH

GM and founder of Intabio — acquired by SCIEX and commercialized as Intabio ZT. Built and launched analytical products at Affymetrix, Caliper, ProteinSimple, and Intabio. Entrepreneur-in-Residence at Genoa Ventures. BS Biology, MIT. 50+ patents.

Scott Mack

CSO · Co-founder · Milpitas, CA

App and development lead for Intabio ZT and the Maurice family at ProteinSimple. Analytical systems development at Beckman-Coulter, ProteinSimple, SCIEX, Intabio, and Bio-Techne. 23+ patents. MS Information Systems, BS Biochemistry · CSU Fullerton.

Everyone here has built instruments before.

Morten Jensen

Engineering Lead

CEO and co-founder of Gate Scientific. Electrical engineer with 30 years in electronics and microfluidic design — Caliper, Abaxis, Intabio. Manages the Gate–Faraday product development program.

Jocelyn Davé

Head of Marketing

Former CEO of Countable Labs. Former CPO/GM at NanoTemper. Former Head of Marketing and Product Development at ProteinSimple. 20+ years of go-to-market for scientific instrumentation.

Advisors from Eli Lilly and Intabio.

Lena Wu, Ph.D.

Strategic Advisor

CEO and co-founder of Eleni Health. Former CEO and co-founder of Intabio. Business and corporate development at Millennium, Sienna, Cytomics, Caliper, Matterworks, and Phizzle. NIIMBL industry representative.

Tim Blanc

Scientific Advisor

Former Director of Technical Service, Global mAb Network at Eli Lilly. Principal Scientist at Johnson & Johnson. Recipient of the 2021 CE Pharm Award for contributions to capillary electrophoresis in biopharma.

Put this team on your problem.

You've met the people who built Intabio ZT and the Maurice family. Early-access testing is open — bring them the variant-isolation problem you haven't been able to solve.